Where to Buy Furmonertinib？

About Furmonertinib

Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral route of administration.

June/2022, Shanghai Allist Pharmaceuticals Co., Ltd. (stock code: 688578) announced that Furmonertinib had been approved by the National Medical Products Administration (NMPA) of China for use in the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion (19DEL) or exon 21 (L858R) substitution mutations.

Where to Buy Furmonertinib？

Furmonertinib, marketed as
Ivesa (Chinese Brand name :艾弗沙). Currently only available for purchase in Mainland China.

You can also consult us: @RxLibra